{"id":2548,"date":"2022-05-27T18:34:59","date_gmt":"2022-05-27T18:34:59","guid":{"rendered":"https:\/\/en.topic.lk\/?p=2548"},"modified":"2022-05-27T18:35:03","modified_gmt":"2022-05-27T18:35:03","slug":"morison-commences-commercial-production-at-state-of-the-art-new-pharmaceutical-manufacturing-facility","status":"publish","type":"post","link":"https:\/\/topic.lk\/2548\/","title":{"rendered":"Morison Commences Commercial Production at State-of-the-Art New Pharmaceutical Manufacturing Facility"},"content":{"rendered":"

Addresses national need with Chlorphenamine Oral Solution\u00a0 and <\/em>Paracetamol 500mg tablets<\/em>\u00a0production<\/em><\/span><\/p>\n\n

Morison Ltd., one of the pioneers of pharmaceutical manufacturing in Sri Lanka since 1959, announced the commencement of commercial production at its state-of the-art WHO GMP and EU GMP compliant production facility in Pitipana, Homagama. Unveiled in late 2020 as Sri Lanka\u2019s first and largest general oral solid and liquid dosage pharmaceutical manufacturing facility, the factory marked the launch of commercial production by manufacturing and releasing its 1st<\/sup>\u00a0commercial batches of Chlorphenamine Oral Solution <\/em>and Paracetamol 500mg tablets to the market on the 26th<\/sup>\u00a0of May.<\/p>\n

Marking a new era in the pharmaceutical manufacturing industry in Sri Lanka, with a commitment to increase access of high quality yet affordable medicines, Morison\u2019s investment of LKR 4 billion in its new state-of-the-art pharmaceutical research and manufacturing facility, is\u00a0 the highest\u00a0 investment to date in the local pharma manufacturing industry. The facility,\u00a0 the first general oral solid and liquid dosage manufacturing plant in Sri Lanka, built as per European Union-Good Manufacturing Practice (EU-GMP) specifications and Quality Management Systems, has a capacity to manufacture over 5 Bn tablets and 2 Mn litres of liquid during two shifts,\u00a0 which can cater up to 40% of the national demand.<\/p>\n\n\n